Can Zosyn (piperacillin/tazobactam) be Y‑sited with D5NS (5 % dextrose in normal saline)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Y-Site Compatibility of Zosyn with D5NS

Yes, Zosyn (piperacillin/tazobactam) can be Y-sited with D5NS (5% dextrose in normal saline), as the FDA-approved label explicitly lists 5% dextrose as an acceptable diluent for administration. 1

Direct FDA Label Guidance

The official Zosyn prescribing information confirms that 5% dextrose is an approved diluent for administration. The drug is supplied in GALAXY containers already diluted in solution and can be administered via Y-site with compatible medications using 5% dextrose as the carrier fluid 1.

Key Administration Parameters

Infusion requirements:

  • Administer over at least 30 minutes 1
  • During infusion, it is desirable to discontinue the primary infusion solution 1
  • The thawed solution is stable for 14 days refrigerated or 24 hours at room temperature 1

Important Y-Site Compatibility Considerations

Critical caveat regarding aminoglycosides: The FDA label provides specific guidance that when Y-site co-administration with aminoglycosides is necessary, only EDTA-containing formulations of Zosyn are compatible, and only with:

  • Amikacin (1.75-7.5 mg/mL) using 0.9% sodium chloride OR 5% dextrose 1
  • Gentamicin (0.7-3.32 mg/mL) using 0.9% sodium chloride OR 5% dextrose, with dose-specific restrictions 1
  • Tobramycin is NOT compatible for Y-site administration 1

Supporting Research Evidence

Research confirms that piperacillin/tazobactam maintains stability in both 5% dextrose and normal saline solutions 2, 3. The reformulated Zosyn product (containing EDTA and citric acid) has expanded compatibility profiles compared to older formulations 4.

Physical compatibility studies demonstrate that Zosyn at concentrations of 22.5-90 mg/mL in 5% dextrose remains chemically stable and physically compatible when stored appropriately 3.

Clinical Practice Recommendation

Use D5NS freely as a carrier solution for Zosyn administration. However, always verify compatibility of any other medications being co-administered via the same Y-site, particularly aminoglycosides which have specific concentration and diluent requirements. When in doubt about co-administered medications not listed in the FDA label, consult your pharmacy for compatibility data or use separate IV access.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.